Everyone (Public)

PeerVoice Head and Neck Cancer CME Hybrid Symposium: After More Than a Decade: Can We Now Enhance Treatment of Patients With LA SCCHN?

720 South Michigan Avenue

https://cme.peervoice.com/505204790_1/505204790_1_p1/stage1reg?AudienceID=Twitter&Promocode=815&CountryID=US&ProjectNumber=505204790_1

Add event to Calendar

This is a hybrid event.

On-site location: Hilton Chicago

6:30 PM:

Dinner and Registration

7:00 PM:

Welcome and Introduction

Kevin Harrington, PhD, FRCR, FRCP

7:05 PM:

Enhancing Outcomes in CRT-Eligible Patients With LA SCCHN: Are We Doing Enough?

Ezra Cohen, MD, FRCPSC, FASCO

7:20 PM:

Deep Diving the Data for Emerging Therapies in LA SCCHN: A Rational Approach to Improving Outcomes

Barbara Burtness, MD

7:35 PM:

Emerging Therapies With the Patient in Mind: What Does the Future Hold?Kevin Harrington, PhD, FRCR, FRCP

7:50 PM:

“Ask the Faculty” and Take-Home Messages

Entire Panel led by Kevin Harrington, PhD, FRCR, FRCP

Speakers

Barbara Burtness, MD
Anthony N. Brady Professor of Medicine (Medical Oncology); Chief Translational Research Officer, Yale Cancer Center; Chief, Head and Neck Cancers/Sarcoma; Co-Leader, Developmental Therapeutics, Yale Cancer Center; Associate Cancer Center Director for Translational Research, Yale Cancer Center
The Institute of Cancer Research, The Royal Marsden Hospital, London, United Kingdom
Kevin Harrington, PhD, FRCR, FRCP
University of California San Diego, UC San Diego Moores Cancer Center, La Jolla, California
Ezra Cohen, MD, FRCPSC, FASCO

Contact

Barbara Burtness, MD

barbara.burtness@yale.edu

Admission

Free

Tag

Conferences and Symposia

Food

Dinner